Literature DB >> 21488135

Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction.

Susanne Thiele1, Luisa de Sanctis, Ralf Werner, Joachim Grötzinger, Cumhur Aydin, Harald Jüppner, Murat Bastepe, Olaf Hiort.   

Abstract

Pseudohypoparathyroidism type Ia (PHPIa) is caused by GNAS mutations leading to deficiency of the α-subunit of stimulatory G proteins (Gsα) that mediate signal transduction of G protein-coupled receptors via cAMP. PHP type Ic (PHPIc) and PHPIa share clinical features of Albright hereditary osteodystrophy (AHO); however, in vitro activity of solubilized Gsα protein is normal in PHPIc but reduced in PHPIa. We screened 32 patients classified as PHPIc for GNAS mutations and identified three mutations (p.E392K, p.E392X, p.L388R) in four unrelated families. These and one novel mutation associated with PHPIa (p.L388P) were introduced into a pcDNA3.1(-) expression vector encoding Gsα wild-type and expressed in a Gsα-null cell line (Gnas(E2-/E2-) ). To investigate receptor-mediated cAMP accumulation, we stimulated the endogenous expressed β(2) -adrenergic receptor, or the coexpressed PTH or TSH receptors, and measured the synthesized cAMP by RIA. The results were compared to receptor-independent cholera toxin-induced cAMP accumulation. Each of the mutants associated with PHPIc significantly reduced or completely disrupted receptor-mediated activation, but displayed normal receptor-independent activation. In contrast, PHPIa associated p.L388P disrupted both receptor-mediated activation and receptor-independent activation. We present a new subgroup of PHP that is caused by Gsα deficiency and selectively affects receptor coupling functions of Gsα.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488135      PMCID: PMC3103608          DOI: 10.1002/humu.21489

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  29 in total

1.  GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance.

Authors:  Agnès Linglart; Jean Claude Carel; Michèle Garabédian; Tran Lé; Eric Mallet; Marie Laure Kottler
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

2.  Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism.

Authors:  M A Levine; R W Downs; M Singer; S J Marx; G D Aurbach; A M Spiegel
Journal:  Biochem Biophys Res Commun       Date:  1980-06-30       Impact factor: 3.575

3.  Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism.

Authors:  Luisa De Sanctis; Damiano Romagnolo; Martina Olivero; Fabio Buzi; Mohamad Maghnie; Giuseppe Scirè; Antonio Crino; Giampiero Igli Baroncelli; Mariacarolina Salerno; Salvatore Di Maio; Marco Cappa; Salvatore Grosso; Franco Rigon; Roberto Lala; Carlo De Sanctis; Irma Dianzani
Journal:  Pediatr Res       Date:  2003-03-05       Impact factor: 3.756

Review 4.  G protein mutations in endocrine diseases.

Authors:  A Lania; G Mantovani; A Spada
Journal:  Eur J Endocrinol       Date:  2001-11       Impact factor: 6.664

5.  Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity.

Authors:  Z Farfel; V M Brothers; A S Brickman; F Conte; R Neer; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

6.  Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy.

Authors:  W Ahrens; O Hiort; P Staedt; T Kirschner; C Marschke; K Kruse
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

7.  Receptor-mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory G protein alpha-subunit.

Authors:  Murat Bastepe; Yasemin Gunes; Beatriz Perez-Villamil; Joy Hunzelman; Lee S Weinstein; Harald Jüppner
Journal:  Mol Endocrinol       Date:  2002-08

8.  Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.

Authors:  Giovanna Mantovani; Luisa de Sanctis; Anna Maria Barbieri; Francesca M Elli; Valentina Bollati; Valentina Vaira; Pamela Labarile; Sara Bondioni; Erika Peverelli; Andrea G Lania; Paolo Beck-Peccoz; Anna Spada
Journal:  J Clin Endocrinol Metab       Date:  2010-01-08       Impact factor: 5.958

Review 9.  Gs(alpha) mutations and imprinting defects in human disease.

Authors:  Lee S Weinstein; Min Chen; Jie Liu
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

Review 10.  The GNAS locus and pseudohypoparathyroidism.

Authors:  Murat Bastepe
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

View more
  22 in total

1.  Postnatal establishment of allelic Gαs silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gαs disruption.

Authors:  Serap Turan; Eduardo Fernandez-Rebollo; Cumhur Aydin; Teuta Zoto; Monica Reyes; George Bounoutas; Min Chen; Lee S Weinstein; Reinhold G Erben; Vladimir Marshansky; Murat Bastepe
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

2.  Case 17-2017. A 14-Year-Old Boy with Acute Fear of Choking while Swallowing.

Authors:  Ryan W Carroll; Michelle L Katz; Elahna Paul; Harald Jüppner
Journal:  N Engl J Med       Date:  2017-06-08       Impact factor: 91.245

Review 3.  GNAS Spectrum of Disorders.

Authors:  Serap Turan; Murat Bastepe
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

Review 4.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

Review 5.  Pseudohypoparathyroidism: one gene, several syndromes.

Authors:  O Tafaj; H Jüppner
Journal:  J Endocrinol Invest       Date:  2016-12-19       Impact factor: 4.256

Review 6.  An update on the clinical and molecular characteristics of pseudohypoparathyroidism.

Authors:  Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

Review 7.  The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene.

Authors:  Serap Turan; Murat Bastepe
Journal:  Horm Res Paediatr       Date:  2013-10-03       Impact factor: 2.852

8.  Cognitive and behavioral phenotype of children with pseudohypoparathyroidism type 1A.

Authors:  Katia M Perez; Evon B Lee; Sachini Kahanda; Jessica Duis; Monica Reyes; Harald Jüppner; Ashley H Shoemaker
Journal:  Am J Med Genet A       Date:  2017-11-28       Impact factor: 2.802

Review 9.  Epidemiology and Diagnosis of Hypoparathyroidism.

Authors:  Bart L Clarke; Edward M Brown; Michael T Collins; Harald Jüppner; Peter Lakatos; Michael A Levine; Michael M Mannstadt; John P Bilezikian; Anatoly F Romanischen; Rajesh V Thakker
Journal:  J Clin Endocrinol Metab       Date:  2016-03-04       Impact factor: 5.958

Review 10.  The Molecular Basis of Calcium and Phosphorus Inherited Metabolic Disorders.

Authors:  Anna Papadopoulou; Evangelia Bountouvi; Fotini-Eleni Karachaliou
Journal:  Genes (Basel)       Date:  2021-05-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.